Andrew D. Ellington

Andrew D. Ellington (born 1956) is an American biochemist and synthetic biologist who is a professor at the University of Texas at Austin. He holds the Wilson M. and Kathryn Fraser Professorship in Biochemistry at UT Austin and was selected as a Howard Hughes Medical Institute (HHMI) Professor in 2017. Ellington is best known for his work on in vitro selection techniques and is credited with coining the term "aptamer" to describe nucleic acid molecules that bind specific targets. His laboratory’s research spans directed evolution, nucleic acid engineering, and synthetic biology, including the development of aptamers, ribozymes, and diagnostic biosensors. Provided by Wikipedia